FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137231365> ?p ?o ?g. }

• W3137231365 abstract "Abstract Introduction Patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations are at risk of further readmissions, increased treatment costs, and excess mortality. This study evaluated inpatient admissions and readmissions in patients receiving initial maintenance therapy with umeclidinium/vilanterol (UMEC/VI) versus tiotropium (TIO). Methods This retrospective, matched cohort study identified patients with COPD who initiated maintenance therapy with UMEC/VI or TIO from Optum’s de-identified Clinformatics Data Mart database between January 1, 2013, and December 31, 2018 (index date defined as earliest dispensing). Eligibility criteria included: ≥ 1 medical claim for COPD pre-index or on the index date; ≥ 12 months of continuous eligibility pre-index; age ≥ 40 years at index; no pre- or post-index asthma diagnosis; and no pre-index claims for medications containing inhaled corticosteroids, long-acting β 2 -agonists, or long-acting muscarinic antagonists. Outcomes included time to first on-treatment COPD-related inpatient admission, rate of on-treatment COPD-related admissions, and rate of all-cause and COPD-related readmissions within 30 and 90 days. Propensity score matching was used to adjust for potential confounders. Results Matched UMEC/VI and TIO cohorts each included 7997 patients and were balanced on baseline characteristics (mean age 70.9 years; female 47.1–47.6%). Over 12 months, patients initiating UMEC/VI had significantly reduced risk (hazard ratio [95% CI]: 0.87 [0.79, 0.96]; p = 0.006) and rates (rate ratio [95% CI]: 0.80 [0.72, 0.92]; p = 0.008) of COPD-related inpatient admissions compared with TIO. While all-cause readmission rates were similar between treatment cohorts, readmission rates among patients with an initial admission length of stay of 1–3 days were numerically lower for UMEC/VI versus TIO (30-day readmissions: 10.5% vs. 12.4%; 90-day readmissions: 15.5% vs. 19.8%). Similar patterns were observed for COPD-related readmissions. Conclusions These findings highlight the real-world benefits of dual therapy with UMEC/VI versus TIO in reducing inpatient admissions and readmissions in patients with COPD, which may translate to lower healthcare costs." @default.
• W3137231365 created "2021-03-29" @default.
• W3137231365 creator A5007477990 @default.
• W3137231365 creator A5015376366 @default.
• W3137231365 creator A5017834828 @default.
• W3137231365 creator A5039497950 @default.
• W3137231365 creator A5059446026 @default.
• W3137231365 creator A5061998147 @default.
• W3137231365 creator A5063896009 @default.
• W3137231365 creator A5074154777 @default.
• W3137231365 creator A5074829480 @default.
• W3137231365 date "2021-03-17" @default.
• W3137231365 modified "2023-10-18" @default.
• W3137231365 title "Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease" @default.
• W3137231365 cites W1868068011 @default.
• W3137231365 cites W1920721512 @default.
• W3137231365 cites W1993396326 @default.
• W3137231365 cites W2009048836 @default.
• W3137231365 cites W2024414191 @default.
• W3137231365 cites W2026585673 @default.
• W3137231365 cites W2036278969 @default.
• W3137231365 cites W2057780602 @default.
• W3137231365 cites W2066161938 @default.
• W3137231365 cites W2102344329 @default.
• W3137231365 cites W2105234929 @default.
• W3137231365 cites W2127895332 @default.
• W3137231365 cites W2193352537 @default.
• W3137231365 cites W2290115254 @default.
• W3137231365 cites W2294615794 @default.
• W3137231365 cites W2593670800 @default.
• W3137231365 cites W2601087692 @default.
• W3137231365 cites W2795842221 @default.
• W3137231365 cites W2801099623 @default.
• W3137231365 cites W2892375223 @default.
• W3137231365 cites W2911491307 @default.
• W3137231365 cites W2965866848 @default.
• W3137231365 cites W3007745370 @default.
• W3137231365 doi "https://doi.org/10.1007/s41030-021-00151-y" @default.
• W3137231365 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8137777" @default.
• W3137231365 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33728597" @default.
• W3137231365 hasPublicationYear "2021" @default.
• W3137231365 type Work @default.
• W3137231365 sameAs 3137231365 @default.
• W3137231365 citedByCount "1" @default.
• W3137231365 countsByYear W31372313652021 @default.
• W3137231365 crossrefType "journal-article" @default.
• W3137231365 hasAuthorship W3137231365A5007477990 @default.
• W3137231365 hasAuthorship W3137231365A5015376366 @default.
• W3137231365 hasAuthorship W3137231365A5017834828 @default.
• W3137231365 hasAuthorship W3137231365A5039497950 @default.
• W3137231365 hasAuthorship W3137231365A5059446026 @default.
• W3137231365 hasAuthorship W3137231365A5061998147 @default.
• W3137231365 hasAuthorship W3137231365A5063896009 @default.
• W3137231365 hasAuthorship W3137231365A5074154777 @default.
• W3137231365 hasAuthorship W3137231365A5074829480 @default.
• W3137231365 hasBestOaLocation W31372313651 @default.
• W3137231365 hasConcept C126322002 @default.
• W3137231365 hasConcept C167135981 @default.
• W3137231365 hasConcept C17923572 @default.
• W3137231365 hasConcept C207103383 @default.
• W3137231365 hasConcept C2776780178 @default.
• W3137231365 hasConcept C2776968687 @default.
• W3137231365 hasConcept C2777714996 @default.
• W3137231365 hasConcept C3018587741 @default.
• W3137231365 hasConcept C44249647 @default.
• W3137231365 hasConcept C71924100 @default.
• W3137231365 hasConceptScore W3137231365C126322002 @default.
• W3137231365 hasConceptScore W3137231365C167135981 @default.
• W3137231365 hasConceptScore W3137231365C17923572 @default.
• W3137231365 hasConceptScore W3137231365C207103383 @default.
• W3137231365 hasConceptScore W3137231365C2776780178 @default.
• W3137231365 hasConceptScore W3137231365C2776968687 @default.
• W3137231365 hasConceptScore W3137231365C2777714996 @default.
• W3137231365 hasConceptScore W3137231365C3018587741 @default.
• W3137231365 hasConceptScore W3137231365C44249647 @default.
• W3137231365 hasConceptScore W3137231365C71924100 @default.
• W3137231365 hasFunder F4320307773 @default.
• W3137231365 hasLocation W31372313651 @default.
• W3137231365 hasLocation W31372313652 @default.
• W3137231365 hasOpenAccess W3137231365 @default.
• W3137231365 hasPrimaryLocation W31372313651 @default.
• W3137231365 hasRelatedWork W10414013 @default.
• W3137231365 hasRelatedWork W12611789 @default.
• W3137231365 hasRelatedWork W126835 @default.
• W3137231365 hasRelatedWork W129920 @default.
• W3137231365 hasRelatedWork W14060578 @default.
• W3137231365 hasRelatedWork W15963216 @default.
• W3137231365 hasRelatedWork W17572523 @default.
• W3137231365 hasRelatedWork W1997541 @default.
• W3137231365 hasRelatedWork W4124819 @default.
• W3137231365 hasRelatedWork W7168267 @default.
• W3137231365 isParatext "false" @default.
• W3137231365 isRetracted "false" @default.
• W3137231365 magId "3137231365" @default.
• W3137231365 workType "article" @default.